Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 1, 2015, Pages 313-315

  Vergara López, Salvador ^a   Carmen Dominguez M ^b   Carmen Conejo, M ^c   Pascual, Álvaro ^c,d   Rodríguez Baño, Jesús ^c,d  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b Hospital La Merced   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Adverse effects; bacteraemia treatment; Carbapenem resistance; Carbapenemases; Infectious endocarditis

Indexed keywords

AMIKACIN; COLISTIN; FOSFOMYCIN; IMIPENEM; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; IMP-8 ENZYME;

ABDOMINAL INFECTION; AGED; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL ENDOCARDITIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CAUCASIAN; CONJUNCTIVAL HEMORRHAGE; DRUG SUBSTITUTION; ELECTIVE SURGERY; FEVER; FOLEY BALLOON CATHETER; HEMATURIA; HUMAN; HYPOKALEMIA; KLEBSIELLA OXYTOCA; LETTER; MALE; METALLO BETA LACTAMASE PRODUCING KLEBSIELLA OXYTOCA; METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; RECTUM CANCER; SHORT BOWEL SYNDROME; TOTAL COLON RESECTION; TOTAL PARENTERAL NUTRITION; TRANSTHORACIC ECHOCARDIOGRAPHY; COINFECTION; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; PATHOLOGY; PENICILLIN RESISTANCE; SECRETION (PROCESS); STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME;

AGED; AMIKACIN; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; COINFECTION; FOSFOMYCIN; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MALE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84928337559     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku341     Document Type: Letter

References (10)

1. van Duin D, Kaye KS, Neuner EA et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013; 75: 115-20.
2. Miró JM, Entenza JM, Del Río A et al. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2012; 56: 4511-5.
3. Chu VH, Cabell CH, Abrutyn E et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004; 39: 1527-30.
4. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009; 30: 2369-413.
5. Aguado JM. Native valve endocarditis caused by Staphylococcus epidermidis. Enferm Infect Microbiol Clin 1989; 7: 210-6.
6. Daikos GL, Markogiannakis A, Souli M et al. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective. Expert Rev Anti Infect Ther 2012; 10: 1393-404.
7. Marchese A, Gualco L, Debbia EA et al. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents 2003; 22: 53-9.
8. Falagas ME, Lourida P, Poulikakos P et al. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 2014; 58: 654-63.
9. Yanagida C, Ito K, Komiya I et al. Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue. Chem Biol Interact 2004; 148: 139-47.
10. Florent A, Chichmanian RM, Cua E et al. Adverse events associated with intravenous fosfomycin. Int J Antimicrob Agents 2011; 37: 82-3.